Tissue microarray analysis reveals site-specific prevalence of oncogene amplifications in head and neck squamous cell carcinoma.

Fluorescence in situ hybridization was applied on a collection of 609 squamous cell carcinomas of the head and neck (HNSCCs),including 511 primary carcinomas of different clinical stage and anatomical localization and 98 recurrent carcinomas, second primary carcinomas, and regional metastases on a tissue microarray. The overall prevalence of amplifications of five oncogenes analyzed was 34.5% for CCND1, 12.7% for EGFR, 8.8% for MYC, 6.2% for ZNF217, and 3.6% for ERBB2. CCND1 amplifications were associated with the pharyngeal site in primary carcinomas (P < 0.001), whereas amplifications of ZNF217 were less frequent in pharyngeal carcinomas as compared with primary oral and laryngeal carcinomas (P = 0.02). The amplification pattern of these oncogenes suggests that different molecular pathways are involved in HNSCCs of different localizations.

[1]  Taylor Murray,et al.  Cancer statistics, 1999 , 1999, CA: a cancer journal for clinicians.

[2]  Alejandro A Schäffer,et al.  Genetic differences detected by comparative genomic hybridization in head and neck squamous cell carcinomas from different tumor sites: construction of oncogenetic trees for tumor progression , 2002, Genes, chromosomes & cancer.

[3]  S. Petersen,et al.  Genetic imbalances with impact on survival in head and neck cancer patients. , 2000, The American journal of pathology.

[4]  O. Kallioniemi,et al.  Tissue microarray technology for high-throughput molecular profiling of cancer. , 2001, Human molecular genetics.

[5]  S. Piantadosi,et al.  Poster 7: A Genetic Progression Model for Head and Neck Cancer: Implications for Field Cancerization , 1996, Cancer research.

[6]  G. Reifenberger,et al.  Recurrent chromosomal imbalances detected in biopsy material from oral premalignant and malignant lesions by combined tissue microdissection, universal DNA amplification, and comparative genomic hybridization. , 1998, The American journal of pathology.

[7]  J. Califano,et al.  Molecular pathology of head‐and‐neck cancer , 2004, International journal of cancer.

[8]  Holger Moch,et al.  Advances in Brief Survey of Gene Amplifications during Prostate Cancer Progression by High-Throughput Fluorescence in Situ Hybridization on Tissue Microarrays 1 , 1999 .

[9]  M. Lim,et al.  Frequent cyclin D1 gene amplification and protein overexpression in oral epithelial dysplasias. , 2001, Oral oncology.

[10]  J. Constantinidis,et al.  DNA amplification on chromosome 7q in squamous cell carcinoma of the tongue. , 2001, International Journal of Oncology.

[11]  F. Moatamed,et al.  Detection of chromosome 11q13 amplification in head and neck cancer using fluorescence in situ hybridization. , 1999, Anticancer research.

[12]  Lorenz,et al.  Different numerical chromosomal aberrations detected by FISH in oropharyngeal, hypopharyngeal and laryngeal squamous cell carcinoma , 1999, Histopathology.

[13]  J. Rodrigo,et al.  EMS1 gene amplification correlates with poor prognosis in squamous cell carcinomas of the head and neck. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[14]  Benjamin D. Smith,et al.  Characterization of the HER-2/neu oncogene by immunohistochemical and fluorescence in situ hybridization analysis in oral and oropharyngeal squamous cell carcinoma. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[15]  E. Schuuring,et al.  Differences in expression of oncogenes and tumor suppressor genes in different sites of head and neck squamous cell. , 1998, Anticancer research.

[16]  J W Gray,et al.  Positional cloning of ZNF217 and NABC1: genes amplified at 20q13.2 and overexpressed in breast carcinoma. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[17]  D. Slamon,et al.  Assessment of methods for tissue-based detection of the HER-2/neu alteration in human breast cancer: a direct comparison of fluorescence in situ hybridization and immunohistochemistry. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  A. C. Johannessen,et al.  Expression of c-erbB proto-oncogene family members in squamous cell carcinoma of the head and neck. , 1997, Anticancer research.

[19]  M. Fukumoto,et al.  Cyclin‐D1‐gene amplification is a more potent prognostic factor than its protein over‐expression in human head‐and‐neck squamous‐cell carcinoma , 1997, International journal of cancer.